However, the significant increase in insulin levels in both silibinin‐treated groups compared to the diabetes group implies that silibinin might enhance beta cell survival and avoid apoptosis, as shown in different studies (Chen et al., 2014; Rahimifard et al., 2018). Here, INS is linked to diabetes mellitus.